Oracle is actively promoting its AI data center progress and job creation efforts amidst significant investor concerns. The company's massive $300 billion OpenAI cloud contract, signed in September ...

Oracle (ORCL) shares jumped 10% today after dropping 60% from September highs above $345. Oracle plans to raise $45B to $50B this year through debt and equity to fund cloud infrastructure expansion.

Oracle (ORCL) just made a bold move that’s sending mixed signals to investors. The software giant announced a $20 billion equity distribution agreement, effectively allowing itself the flexibility to ...

Oracle faces a class action lawsuit from bondholders claiming the company misled investors. Wall Street analysts slashed price targets across the board over AI spending. Microsoft's earnings didn't ...

Oracle remains “committed” to its mission of transforming healthcare, according to Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. “Whether it is helping ...

Oracle's shares may be oversold. OpenAI and TikTok should help to fuel the cloud giant's growth. The sell-off in Oracle's shares is overdone. That's according to Davidson analyst Gil Luria, who ...

Investors allege Oracle misled them about AI infrastructure returns while top executives unloaded shares at inflated prices. A securities class action filed this week in Delaware federal court accuses ...

Big Tech stocks tried to rally Monday after a week that saw more than $1 trillion wiped from their market caps. Oracle led the gains among the tech names. Market concerns came as companies announced ...

Hammered by the general software selloff and AI debt concerns, shares of Oracle have shed 25% over eight trading sessions Oracle issued $25 billion of corporate bonds on Monday as part of its 2026 ...

Every time Theron publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

The latest price target for Oracle (NYSE:ORCL) was reported by Morgan Stanley on January 23, 2026. The analyst firm set a price target for $213.00 expecting ORCL to rise to within 12 months (a ...